000293347 001__ 293347
000293347 005__ 20250826125945.0
000293347 0247_ $$2doi$$a10.1016/j.euros.2024.01.010
000293347 0247_ $$2ISSN$$a2666-1691
000293347 0247_ $$2ISSN$$a2666-1683
000293347 037__ $$aDKFZ-2024-01893
000293347 082__ $$a610
000293347 1001_ $$aAl-Monajjed, Rouvier$$b0
000293347 245__ $$aScreening for Prostate Cancer with Prostate-specific Antigen
000293347 260__ $$a[Amsterdam]$$bElsevier ScienceDirect$$c2025
000293347 3367_ $$2DRIVER$$aarticle
000293347 3367_ $$2DataCite$$aOutput Types/Journal article
000293347 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1743172384_31629$$xLetter
000293347 3367_ $$2BibTeX$$aARTICLE
000293347 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000293347 3367_ $$00$$2EndNote$$aJournal Article
000293347 500__ $$aVolume 74, April 2025, Pages 71-72 / Brief Correspondence
000293347 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000293347 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000293347 7001_ $$0P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aAlbers, Peter$$b1$$udkfz
000293347 7001_ $$aHadaschik, Boris$$b2
000293347 773__ $$0PERI:(DE-600)3040546-4$$a10.1016/j.euros.2024.01.010$$gp. S2666168324002209$$p71-72$$tEuropean urology open science$$v74$$x2666-1691$$y2025
000293347 8564_ $$uhttps://inrepo02.dkfz.de/record/293347/files/1-s2.0-S2666168324002209-main.pdf
000293347 8564_ $$uhttps://inrepo02.dkfz.de/record/293347/files/1-s2.0-S2666168324002209-main.pdf?subformat=pdfa$$xpdfa
000293347 909CO $$ooai:inrepo02.dkfz.de:293347$$pVDB
000293347 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000293347 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000293347 9141_ $$y2024
000293347 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-12-04T14:46:26Z
000293347 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-12-04T14:46:26Z
000293347 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2020-12-04T14:46:26Z
000293347 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR UROL OPEN SCI : 2022$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-27
000293347 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-27
000293347 9201_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x0
000293347 980__ $$ajournal
000293347 980__ $$aVDB
000293347 980__ $$aI:(DE-He78)C130-20160331
000293347 980__ $$aUNRESTRICTED